Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (361-370 of 449) with videos related to

Pageof 45
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS SubstudyHeinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, et al.
Neuroimage. Clinical|January 14, 2020
Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidenceRichard McKinley, Rik Wepfer, Lorenz Grunder, et al.
Brain : a Journal of Neurology|January 15, 2015
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Jordi Río, Elena Urcelay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 29, 2019
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosisLaura Barin, Christian P Kamm, Anke Salmen, et al.
American Journal of Epidemiology|September 7, 2018
Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct EffectsJames Y Dai, Ulrike Peters, Xiaoyu Wang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2021
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing dataAlasdair J Coles, Joanne L Jones, Patrick Vermersch, et al.
Acta Neuropathologica|April 29, 2019
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosisRobert Hoepner, Maud Bagnoud, Maximilian Pistor, et al.
Gastrointestinal Endoscopy|May 25, 2021
Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimatedEdward H Tsoi, Puneet Mahindra, Georgina Cameron, et al.
Gut|March 16, 2021
Blue poo: impact of gut transit time on the gut microbiome using a novel markerFrancesco Asnicar, Emily R Leeming, Eirini Dimidi, et al.
Journal of Bronchology & Interventional Pulmonology|October 17, 2014
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysemaDouglas E Wood, Daniel A Nader, Steven C Springmeyer, et al.
Pageof 45

Showing results (361-370 of 449) with videos related to

Sort By:
Pageof 45
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS SubstudyHeinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, et al.
Neuroimage. Clinical|January 14, 2020
Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidenceRichard McKinley, Rik Wepfer, Lorenz Grunder, et al.
Brain : a Journal of Neurology|January 15, 2015
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Jordi Río, Elena Urcelay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 29, 2019
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosisLaura Barin, Christian P Kamm, Anke Salmen, et al.
American Journal of Epidemiology|September 7, 2018
Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct EffectsJames Y Dai, Ulrike Peters, Xiaoyu Wang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2021
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing dataAlasdair J Coles, Joanne L Jones, Patrick Vermersch, et al.
Acta Neuropathologica|April 29, 2019
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosisRobert Hoepner, Maud Bagnoud, Maximilian Pistor, et al.
Gastrointestinal Endoscopy|May 25, 2021
Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimatedEdward H Tsoi, Puneet Mahindra, Georgina Cameron, et al.
Gut|March 16, 2021
Blue poo: impact of gut transit time on the gut microbiome using a novel markerFrancesco Asnicar, Emily R Leeming, Eirini Dimidi, et al.
Journal of Bronchology & Interventional Pulmonology|October 17, 2014
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysemaDouglas E Wood, Daniel A Nader, Steven C Springmeyer, et al.
Pageof 45